| Literature DB >> 35501528 |
Marilyn N Martinez1, Fang Wu2, Balint Sinko3, David J Brayden4, Michael Grass5, Filippos Kesisoglou6, Aaron Stewart5,7, Kiyohiko Sugano8.
Abstract
It is now recognized that a number of excipients previously considered to be "inert" have the capacity to alter drug oral bioavailability through a range of in vivo effects. The various mechanisms through which an excipient can affect in vivo gastrointestinal physiology and drug absorption characteristics were explored in "A Critical Overview of The Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption." The next critical issue that needs to be discussed is how these biological effects are evaluated. Therefore, in Part 2 of this critical overview, the in vitro, in vivo, and in silico methods for evaluating excipient effects are considered. Examples are provided to illustrate how such studies employing these various procedures have been used to promote formulation understanding and optimization. Finally, a discussion of how the Center for Drug Evaluation and Research applies these tools to support biowaivers is provided.Entities:
Keywords: bioavailability; ex vivo methods; excipient effects; in situ methods; in vitro assays; modeling and simulation
Mesh:
Substances:
Year: 2022 PMID: 35501528 DOI: 10.1208/s12248-022-00713-1
Source DB: PubMed Journal: AAPS J ISSN: 1550-7416 Impact factor: 4.009